News-Medical.Net on MSN
Hybrid polymer nanocarriers enable efficient inhaled mRNA vaccine delivery to the lungs
Novel hybrid polymer nanocarriers enable effective vaccine delivery in the lungs and the targeted activation of immune cells.
Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. Of 9,225 ...
RESUME FLIGHTS TONIGHT. FIVE ON YOUR HEALTH TONIGHT THE FUTURE FOR MRNA VACCINES IS IN JEOPARDY. HHS SECRETARY ROBERT F KENNEDY JR HAS CUT HUNDREDS OF MILLIONS OF DOLLARS IN FUNDING FOR THEM. WELL, A ...
An LMU research team led by Professor Olivia M. Merkel, Chair of Drug Delivery at LMU, has developed a new delivery system ...
In the years since mRNA vaccines were introduced to protect against COVID-19, their benefits seem to extend far beyond preventing infection. Recent research now suggests that these vaccines could also ...
A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Tsinghua University has unveiled a new messenger ribonucleic acid (mRNA) vaccine ...
This article explores how next-generation vaccines are expanding beyond infectious disease to target chronic conditions while ...
A few years before he took over the U.S. Department of Health and Human Services, Robert F. Kennedy Jr. called COVID-19 shots the "deadliest vaccine ever made." More recently, various anti-vaccination ...
The vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Dr Mike ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results